Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Dagan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Unified Clinical Vocabulary Embeddings for Advancing Precision MedicineRuth Johnson, Uri Gottlieb, Galit Shaham, et al.
Nature Communications|September 8, 2020
Developing a COVID-19 mortality risk prediction model when individual-level data are not availableNoam Barda, Dan Riesel, Amichay Akriv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Arxiv|June 4, 2026
Learning Normal Representations for Blood BiomarkersAashna P Shah, Michelle M Li, Yash Lal, et al.
NPJ Digital Medicine|June 11, 2026
Embeddings of clinical codes enable knowledge-grounded AI in medicineRuth Johnson, Uri Gottlieb, Galit Shaham, et al.
The New England Journal of Medicine|June 29, 2022
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of AgeChandra J Cohen-Stavi, Ori Magen, Noam Barda, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
The New England Journal of Medicine|August 24, 2022
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron SurgeRonen Arbel, Yael Wolff Sagy, Moshe Hoshen, et al.
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
Vaccine|December 14, 2021
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)Mark A Katz, Efrat Bron Harlev, Bibiana Chazan, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Unified Clinical Vocabulary Embeddings for Advancing Precision MedicineRuth Johnson, Uri Gottlieb, Galit Shaham, et al.
Nature Communications|September 8, 2020
Developing a COVID-19 mortality risk prediction model when individual-level data are not availableNoam Barda, Dan Riesel, Amichay Akriv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Arxiv|June 4, 2026
Learning Normal Representations for Blood BiomarkersAashna P Shah, Michelle M Li, Yash Lal, et al.
NPJ Digital Medicine|June 11, 2026
Embeddings of clinical codes enable knowledge-grounded AI in medicineRuth Johnson, Uri Gottlieb, Galit Shaham, et al.
The New England Journal of Medicine|June 29, 2022
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of AgeChandra J Cohen-Stavi, Ori Magen, Noam Barda, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
The New England Journal of Medicine|August 24, 2022
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron SurgeRonen Arbel, Yael Wolff Sagy, Moshe Hoshen, et al.
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
Vaccine|December 14, 2021
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)Mark A Katz, Efrat Bron Harlev, Bibiana Chazan, et al.
Pageof 4